THREAD: Presidential Spokesperson @attyharryroque holds a media briefing in Malacañang | LIVE https://t.co/0X6MAKcUyB

Tweets by our digital producers @pplmanuel and @lisbetesmael

Roque recaps the recent hearing of the Senate Committee of the Whole on the government's COVID-19 vaccination plan
Roque: Magkakaroon po ng legal na pananagutan ang drug companies 'pag nagbenta sila ng bakuna for commercial use kahit Emergency Use Authorization use pa lamang meron sila
Roque reiterates government is not favoring Sinovac or any particular vaccine: Dahil napakataas po ng demand, gagamitin natin kung ano ang available https://t.co/vBN7Q3XstM
Roque: Kung gusto mo makakuha ng supply, dapat bultuhan ang order mo. Halos lahat ng bansa centralized ang purchasing. Wala pa tayong alam na pribadong kumpanya na bumibili dahil hindi pa pwede
Roque reminds COVID-19 vaccination is not mandatory: Mismo ang Presidente ang nagsabi: wala pong pilitan
Roque denies that the agreement to procure 25M Sinovac doses is not yet a 'done deal': Kontrata na iyan. That is already a binding obligation
Roque: Sa pagbili ng bakuna, dadaan ito sa multilateral arrangements with fund managers tulad ng ADB, World Bank
Roque says through tripartite agreements, gov't aims to secure doses for LGUs, private companies in lowest possible prices through negotiations
Roque on Sinovac vaccine price: Kapag nabayaran na, obligado nang sabihin kung magkano talaga ang nabayaran. Ngayon ang napirmahan ay term sheet, isa din iyang kontrata to sell and buy. Pero ang kondisyon ay kailangan ma-approve ng FDA, among others
Roque on 17M doses from AstraZeneca: 2.5M doses were ordered by the private sector, due for delivery this May; 14.5M doses were ordered by 39 LGUs and 300 companies to be delivered Q3 or Q4 2021
Roque reminds only American firm Pfizer has successfully secured an Emergency Use Authorization from the Food and Drug Administration https://t.co/FbTQ4JUih7
Meanwhile, AstraZeneca, Sinovac and Gamaleya have already submitted applications for EUA
Roque: Supply at demand: kung ano ang napatunayang ligtas, epektibo, ito ang gagamitin natin. Nais nating maligtas ang ating mga kababayan sa madaling panahon
Roque reiterates inoculation in the Philippines will only start if the vaccine has secured emergency use authorization from the FDA
Roque on China Foreign Minster Wang Yi's recent PH visit: The President has emphasized the need to strengthen PH, China's cooperation on public health matters
Roque: Sinabi ni Minister Wang Yi magdodonate ang China ng 500,000 doses ng vaccine sa bansa https://t.co/wqmqkCUJxw
Roque says Foreign Minister Wang Yi vows China will continue to support Duterte administration's infrastructure program
Roque takes a jab at Vice Ganda: Dahil sa limitadong supply ng bakuna, hindi tayo makakapili mula sa isa o dalawang brand. Mali na ikumpara ang bakuna sa sabon na panlaba... Kung hindi pagkakatiwalaan ang experts, sino ang ating pagkakatiwalaan? Siguro hindi mga komedyante
Comedian Vice Ganda reacted to Roque's comment last week that Filipinos cannot be choosy when it comes to vaccine brands https://t.co/gBfqjQEZes
Roque announces the modification of import duty rates on certain agri products as stated in Executive Order No. 123
Roque: Patuloy ang kumpyansa sa ekonomiya natin, pinatutunayan ito ng malakas na pagsara ng piso. Nung Biyernes, nagsara ang piso sa ₱48.065 = $1
Roque: Bagama't may mga nagsasabing 'di maganda ang paglakas ng piso dahil magmamahal ang exports, patunay po ito sa maraming nagku-kumpyansa sa ekonomiya
Roque on PH COVID-19 cases breaching 500K mark: 'Wag naman po tayong mag-alala dahil ang aktibong mga kaso dito ay 24,691 lamang at maski 500,000 na ang kaso natin, ang position po natin worldwide ay nasa 32nd place with most number of cases https://t.co/B2tHTAqPxQ
Roque: Bumaba din ang available ventilators dahil sa inasahan nating [post-holiday] spike
Roque on healthcare utilization rates per region: Wala pang rehiyon na nasa moderate risk, bagamat malapit na po ang Region XI
Roque: Ang hudyat sa pagbabago ng quarantine classification ay 'pag nasa danger level na po tayo
Infectious diseases specialist Dr. Rontgene Solante on vaccine development: Ang pag-develop ng bakuna, dadaan 'yan sa proseso. Yung pinakamabigat dito ay preclinical study, binibigay pa lang ito sa animals, titignan kung magpoproduce sila ng antibodies, may major side effects ba
Dr. Solante says should a vaccine pass preclinical study, it will then be tested on humans under clinical trials, which come in different phases
Dr. Solante on minimum 50% efficacy rate for vaccines: The WHO determines this threshold, this is based on the percentage of people needed to be vaccinated to control the pandemic, they use mathematical models to compute this
Dr. Solante on differences in Sinovac's efficacy rate: Yung efficacy rate is not always consistent with any population
Dr. Solante says a vaccine's efficacy rate also depends on the makeup of the population it will be administered to
Dr. Solante: Depende rin sa target population na babakunahan. If you are vaccinating 50 years old and below, you will expect higher efficacy rate
Dr. Solante on 29 deaths in Norway linked to Pfizer vaccines: Kailangan nila imbestigahan iyan. If you look at other countries using Pfizer, wala namang namamatay. It's unique in Norway
Dr. Solante says authorities must review whether the deaths are linked to the vaccine or there were some pre-existing factors like comorbidities in concerned patients
Dr. Solante on vaccine efficacy rates: Hihimayin din natin aside from the prevention of infection ang prevention of severe disease
Dr. Solante says studies of vaccines under review in PH point to these vaccines not being affected by the new coronavirus variant so far: It's still impossible it can, but less likely. Still, we have to monitor individuals being vaccinated
Dr. Solante says ethnicity of clinical trial participants also important in reviewing vaccine efficacy
Dr. Solante: So far sa analysis nila sa spike rate sa UK, it seems hindi pa apektado ang bakuna. It still produces the same number of antibodies expected to be produced by a vaccine
Dr. Solante: The presence of comorbidities will make us prioritize these individuals more, they're more prone to getting serious cases
Dr. Solante says so far, clinical trials reveal Pfizer, Moderna, and AstraZeneca are safe to be given across all ages

Dr. Solante: Among the three, they can not really proceed to phase 3 if they're not safe. Sa ngayon, all of these vaccines are safe to be given regardless of age
Roque on remark about Filipinos preferring brands like Pfizer having 'colonial mentality': Pasensya na po kayo, ako nama'y kilala bilang spokesperson na diretso magsalita, katotohanan lamang (1/2)
Roque on remark about Filipinos preferring brands like Pfizer having 'colonial mentality': Ang katotohanan po, yung iba sa atin, lalo na kritiko ng gobyerno, tinitignan lang kung saan galing ang bakuna (2/2)
Roque: Hindi dapat tinitignan saan gawa ang bakuna. Ang dapat na tinitignan natin ay kung ito ay ligtas at epektibo, kahit saan pa sila gawa
Roque on Sinovac price: Ang sabi ni Sec. Galvez, mahigit kumulang kapresyo ng sa Indonesia, mahigit kumulang ₱650 per dose, hindi lalagpas ng ₱700. Iyan ang presyong BFF https://t.co/nLF4NdkywO
Roque on duration of community quarantine: Depende po 'yan sa datos, analytics po ang sinusundan natin. Matagal ko na pong sinangguni, at inaprubahan naman ng IATF, na magkaroon ng new normal classifications para sa mga lugar na matagal nang walang transmission
Roque says the new normal classification has been approved "in principle," but guidelines like do's and don'ts are still being formulated https://t.co/CpNSL43Wjv
Roque says President Duterte will address the nation tonight
Roque on postponement of Anti-Terror Law oral arguments: Sa panahon ng pandemya, walang magsisinungaling na sila'y nagka-COVID o exposure sa COVID https://t.co/uJuKYCmT54
Roque: 50-70M ang target nating mga magbabakuna, mas marami ang kakailangan natin sa pagbabakuna
Roque on President Duterte and Chinese Foreign Minister Yi's discussions: Wala po ako dun, perhaps DFA Sec. Locsin can tell you about the atmosphere [then], I only have the press release and transcript
Roque: It must have been very cordial dahil nagkaroon tayo ng donasyon, commitment to do projects https://t.co/lxpvhrnKK5
Roque on VP Robredo's suggestion to vaccinate Pres. Duterte first against COVID-19 to increase vaccine confidence: 'Yan po ay sinasangguni naman na, ang Presidente po paiba-iba ang kanyang prayoridad sa Talk to the People, hayaan po natin siyang magdesisyon
Roque on 29 deaths in Norway linked to Pfizer vaccine: Kailangan muna pag-aralan 'yan kung dahil ba ito sa Pfizer, 'wag po muna tayo mag-conclude
RELATED: The Food and Drug Administration hopes reports of deaths among the elderly in Norway after receiving COVID-19 vaccine shots will not worsen Filipinos' vaccine hesitancy, its chief says https://t.co/NHsRRSqVAB
Roque on vaccine usage: Meron po tayong cost-benefit analysis, na the benefits outweigh the costs

More from World

All the leftists in the comments like oh no prageru made a good point lol


Polls consistently show conservative support for nuclear energy. It also has high support among elites. The myth that it is unpopular in general isn’t true—although it is unpopular in almost every specific case where they need to site it

Article is old but yeah

This study finds that risk & benefit predict individual opinion the most, followed by the share of nuclear energy already extant, followed by ideology (conservatives support more)

This one finds that journalists attitude affect public perceptions, but that energy consultants, nuclear engineers, bureaucrats, and the military show the highest support for nuclear energy

You May Also Like